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ABSTRACT
Alternative splicing of terminal exons increases tran-
script and protein diversity. How physiological and
pathological stimuli regulate the choice between al-
ternative terminal exons is, however, largely un-
known. Here, we show that Brahma (BRM), the AT-
Pase subunit of the hSWI/SNF chromatin-remodeling
complex interacts with BRCA1/BARD1, which ubiq-
uitinates the 50 kDa subunit of the 3′ end process-
ing factor CstF. This results in the inhibition of tran-
script cleavage at the proximal poly(A) site and a shift
towards inclusion of the distal terminal exon. Upon
oxidative stress, BRM is depleted, cleavage inhibi-
tion is released, and inclusion of the proximal last
exon is favoored. Our findings elucidate a novel reg-
ulatory mechanism, distinct from the modulation of
transcription elongation by BRM that controls alter-
native splicing of internal exons.
INTRODUCTION
Pre-mRNAsplicing and 3′ end processing are essential steps
for the expression of the vast majority of metazoan genes.
Recently, RNAseq analysis showed that not only alternative
splicing (AS) but also alternative polyadenylation (APA) is
more frequent and complex than previously anticipated (1–
4). The choice of alternative poly(A) sites generates differ-
ent 3′ UTRs that can affect translation, stability and local-
ization of the mRNA. Alternative pre-mRNA processing
changes the length of the 3′ UTR during cell differentia-
tion contributing to the regulation of gene expression (5,6).
When coupled to the inclusion of an alternative last exon
(ALE), alternative polyadenylation leads to the generation
of mRNA variants that differ in their 3′ UTR and that may
encode proteins with different C-terminal regions.
Whereas the molecular details of pre-mRNA 3′ end pro-
cessing are rather well known, how the choice of APA
sites is regulated is only partially understood. The mature
3′ ends of most eukaryotic mRNAs are generated by en-
donucleolytic cleavage of the primary transcript followed
by the addition of a poly(A) tail to the upstream cleavage
product (1,7). Maturation of the 3′ end is executed by a
large multicomponent complex that is assembled in a co-
operative manner on specific cis-acting sequence elements
in the pre-mRNA (8,9). In mammalian cells, the cleavage
and polyadenylation specificity factor (CPSF) recognizes
the consensus hexanucleotideAAUAAA,whereas the cleav-
age stimulation factor (CstF), a hexameric complex of sub-
units of 77, 64 and 50 kDa (10,11), binds a more degen-
erate GU- or U-rich element downstream of the poly(A)
site. Both CPSF and CstF interact with RNA polymerase II
(RNAPII) at the promoter and appear to remain associated
with it during elongation (12,13). CstF50 and CstF77 inter-
act specifically with the carboxy-terminal domain (CTD) of
RNAPII largest subunit. CstF50 was also shown to bind
the BARD1/BRCA1 ubiquitin ligase after DNA damage,
resulting in the inhibition of 3′ end processing (14). This
observation and the fact that APA is modulated in devel-
opment, differentiation and neuronal activation (reviewed
in (9)) indicates that 3′ end processing can be regulated in
response to physiological and pathological stimuli.
Oxidative stress is a widely occurring phenomenon in bi-
ological systems, and is due to an imbalance between the
intracellular production or influx of reactive oxygen species
(ROS) and the availability of antioxidant compounds, such
as glutathione. Oxidative stress has been implicated in the
etiology of many neurodegenerative disorders, including
Alzheimer’s and Parkinson’s diseases (15). At the cell level,
oxidative stress elicits a wide spectrum of responses rang-
ing from proliferation to growth arrest, senescence, or cell
death. The particular outcome reflects the balance between
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a variety of intracellular stress signalling pathways that are
activated in response to the oxidative insult and that ulti-
mately modulate gene expression.
We recently described that exposure of human neurob-
lastoma SH-SY5Y cells to different sources of ROS leads
to genome-wide alternative splicing changes, modifying
the relative proportion of alternatively spliced forms (16).
Here, we show that oxidative stress specifically affects the
choice of ALEs increasing the production of transcripts
variants terminating at a more proximal poly(A). Oxida-
tive stress induces the transcriptional downregulation of
Brahma (BRM), one of the two alternative ATPase sub-
units of the SWI/SNF complex. We find that in normal
condition BRM is enriched on the proximal ALE. In ad-
dition we observe the accumulation of BARD1, a protein
that forms a functional heterodimer with BRCA1, which
has E3 ubiquitin-ligase activity and interacts with the 50
kDa subunit of CstF inhibiting 3′ end processing (17). Con-
sistent with these observations, we detect an ubiquitinated
pool of CstF50 and show that ubiquitination is mediated by
BARD1/BRCA1. Taken together, our results suggest that
the presence of BRM on the proximal exon leads to the
BARD1/BRCA1-mediated ubiquitination of CstF50 and
the inhibition of 3′ end processing at the proximal poly(A).
This in turn allows transcription to proceed to the distal ter-
minal exon.
MATERIALS AND METHODS
Cell culture and transfections
Human neuroblastoma SH-SY5Y, SH-SY5Y/SOD1, SH-
SY5Y/SOD1(G93A) and HEK293T cells were cultured in
D-MEM High Glucose medium (Gibco, Invitrogen), 10%
fetal bovine serum (FBS), 2.5 mM L-glutamine, 100 U/ml
penicillin, and 100g/ml streptomycin (Euroclone) at 37◦C
with 5% CO2. Paraquat (Sigma-Aldrich) treatment of SH-
SY5Y cells was carried out as described (16). Resveratrol
(Sigma-Aldrich) was dissolved in DMSO, and cells were
treated with 10 M resveratrol for 24 h. Control cells were
treated with vehicle. Adult dermal fibroblats (ATCC, PCS-
201-012) were cultured D-MEM High Glucose medium
(Gibco, Invitrogen), 10% fetal bovine serum (FBS), 5 mM
L-glutamine, 100 U/ml penicillin and 100 g/ml strepto-
mycin (Euroclone) at 37◦C with 5% CO2. Treatment with 2
mM paraquat was performed for 48 h, while treatment with
0.2 mM H2O2 (Sigma-Aldrich) was performed for 24 h.
Cells were transfected using polyethylenimine (PEI,
Sigma-Aldrich) according to the manufacturer’s instruc-
tions. Stably transfected cells were obtained by selection
with 1 g/ml puromycin (Sigma-Aldrich). For depletion
of BRCA1, HEK293T cells were transfected twice (day 0
and day 3) in six-well plates with 75 pmol of the corre-
sponding Silencer R© select siRNAs and Negative control
siRNA #1 (Ambion). Transfection was carried out using
Lipofectamine R© RNAiMax reagent (Invitrogen) following
manufacturer’s instructions. Cells were expanded and lysed
at day 6.
For BRM-K755A overexpression, cells were electropo-
rated with Amaxa R© nucleofector R© system (Lonza) using
Amaxa R© Cell Line Nucleofector R© Kit V according to the
manufacturer’s instructions.
Intracellular ROS were measured with 2′,7′-
dichlorodihydrofluorescein diacetate (H2DCF-DA;
Sigma-Aldrich, D6883). Cells were exposed to H2DCF-DA
(20 M) during the last 30 min of culture, then collected
and washed with PBS. A blank sample (cells not exposed
to H2DCF-DA) was also prepared. The H2DCF-DA flu-
orescence was measured by flow cytometry after addition
of propidium iodide (PI) to the samples. Only the cellular
population of PI impermeable cells was considered for
measuring the fluorescence intensity of H2DCF-DA (18).
Plasmids and antibodies
The cDNAs encoding the N-terminal flag-tagged human
BRM and N-terminal flag-tagged BRG1 proteins were a
gift from B. Emerson. These cDNAs were subcloned into
the SmaI–SalI (New England Biolabs) sites of the pAD5-
CMV-Wpre-PGK-Puro expression vector (a kind gift from
S. Philipsen). The mutation K755A (19) was introduced us-
ing a two-step mutagenic PCR procedure using Phusion
polymerase (Finnzymes). The interfering shRNA oligonu-
cleotides targeting human SMARCA2 and SMARCA4
transcripts were designed using the SiDesign Center (Dhar-
macon). The shRNA primers were cloned into pSUPuro
vector. pSUPuro, and the pSUPuro ß2 T-Cell Receptor
Beta used as an unrelated control shRNA were gifts from
M.D. Ruepp. BARD1 and BRCA1 constructs were a gift
of N. Chiba. The cDNA encoding CstF50 was subcloned
from pcDNA3 HA-CstF50 (a gift from M.D. Ruepp)
into a p3XFLAG-myc-CMV26 removing the myc tag. The
histidine-tagged Ubiquitin was a gift of M.L. Guerrini. All
constructs were verified by sequencing (BMR Genomics).
All oligonucleotide sequences are listed in Supplementary
Table S2. The commercial antibodies used are listed in the
Supplementary Table S1. Non-immune rabbit IgGs (Mil-
lipore) were used as a control in the immunoprecipitation
assays.
Luciferase assay
SH-SY5Y cells were transiently co-transfected with the
indicated pGL2 luciferase reporter plasmids and with
the Renilla-encoding pRL-TK plasmid (Promega Inc.).
Twenty-four hours after transfection, cells were lysed and
luciferase activity quantified using the Dual Luciferase Re-
porter kit (Promega Inc.) and a Berthold luminometer
(Berthold Technologies). For the luciferase experiments,
paraquat was added 3 h after transfection.
Bioinformatic analysis
Transcripts characterized by alternative splicing
events at their 3′ end were detected by R script-
ing using Bioconductor 2.12 packages Genomi-
cRanges, TxDb.Hsapiens.UCSC.hg19.knownGene
and HuExExonProbesetLocation (www.
bioconductor.org). Transcripts were extracted from
TxDb.Hsapiens.UCSC.hg19.knownGene (80922 tran-
scripts). After removal of transcripts lacking a link to
Entrez Gene Identifier (20), 71 350 transcripts (26 5661
exons), associated to 22 932 EG, were left for further
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analysis. Subsequently, we selected all genes associated
to the presence of alternative splicing even at the 3′ end
(12 839 genes, 58 451 transcripts, 26 608 exons involved
in ALE). Affymetrix Human Exon 1.0 ST Array (HuEx-
1 0-st) exon-level probe sets chromosomal locations were
extracted from HuExExonProbesetLocation (21). Only
exon-level probesets associated to the Affymetrix core
annotation were considered (284805 exon-level probesets).
These exon-level probesets mapped on 12839 genes (59
986 UCSC transcripts, 230 112 exons). Out of the 230
112 exons 22 983 were associated to ALE. Alternatively
spliced exon-level probesets were retrieved by Lenzken
et al. (16). Four hyndred six exon-level probesets mapping
on 418 exons were associated to 262 genes (1191 UCSC
transcripts, 4844 exons). Within the 418 exons 89 exons (78
UCSC genes) were involved in ALE.
RNA analysis
RNA preparation and RT-PCR reactions were performed
as described (16). The sequences of the exon-specific
primers are listed in Supplementary Table S2. Assay con-
ditions were optimized for each gene with respect to primer
annealing temperatures, primer concentrations, andMgCl2
concentrations. Quantification was performed with Bioan-
alyzer 2100 (Agilent Technologies).
Chromatin immunoprecipitation and qPCR analysis
107 SH-SY5Y cells were cross-linked with 1% formaldehyde
(Sigma-Aldrich), and quenched with the addition of 125
mMglycine (Sigma-Aldrich). Cell pellets were lysed in Lysis
Buffer (50mMHEPES–KOHpH7.5, 140mMNaCl, 1mM
EDTA pH 8, 1% Triton X-100, 0.1% sodium deoxycholate,
0.1%SDS, protease inhibitors (Roche) for 1 hour on ice, and
then sonicated with a Branson 250 sonifier (Branson Inc.)
to obtain chromatin fragments of ∼400 nt. Aliquots corre-
sponding to 5× 106 cells were flash-frozen in liquid nitrogen
and then maintained at −80◦C. For each immunoprecipi-
tation, 1% of the total genomic DNA was saved as input
DNA. The chromatin solution was precleared at 4◦C for 1
h with sepharose beads. Immunoprecipitation was carried
out using the Chromatin IP Assay Kit (Millipore), follow-
ing manufacturer’s instructions. Bound material was eluted
with 500 l of Elution Buffer (1% SDS, 100 mMNaHCO3)
for 1 h at room temperature. Crosslinking was reversed at
65◦C overnight, with the addition of 250 mM NaCl and
2 g/ml Proteinase K (Sigma). DNA was purified by phe-
nol:choloform:isoamyl alcohol (Sigma-Aldrich) extraction
and ethanol precipitation. For ChIP-ReChIP experiments,
eluates from the first ChIP assays were diluted in the ChIP
Dilution buffer (Millipore) to reduce the SDS concentration
to 0.1% (w/v). Then, the second ChIP was performed. Im-
munoprecipitatedDNAwas analyzed in triplicate by qPCR
using the SYBR Green method with Mesa Green qPCR
master mix (Biosense) in an ABI PRISM 7500 (Applied
Biosystem). The primers used for the qPCRs are listed in
the Supplemental Table S2. Data were normalized by the
Fold Enrichment Method as follows: Relative Enrichment
= 2 – (Ct antibody- Ct IgG).
Micrococcal nuclease assays
107 SH-SY5Y cells were synchronized in G0 by serum
starvation as assessed by FACS analysis (FACSCalibur,
BD Biosciences). Cells were cross-linked with 1% (v/v)
formaldehyde and quenched with the addition of 125 mM
glycine. Cell pellets were lysed in Lysis Buffer (50 mM
HEPES–KOH pH 7.5, 140 mM NaCl, 1% Triton X-100,
0.1% sodium deoxycholate, 0.1% SDS, protease inhibitors
(Roche). Nuclei were disrupted by five bursts of sonica-
tion. Aliquots of 5 × 106 cells were flash-frozen in liquid
nitrogen and then maintained at −80◦C. One undigested
aliquot was used as control. Digestion was performed with
20 U of Micrococcal Nuclease (Fermentas) in 1 mM final
CaCl2 and MgCl2 for 30 min at room temperature, then
stopped with 20 mM EDTA. Crosslinking was reversed at
65◦C overnight, with the addition of 250 mM NaCl and 2
g/ml Proteinase K followed by phenol:choloform:isoamyl
alcohol extraction and ethanol precipitation. qPCR analy-
sis was performed on 4 ng. The primers used for the qPCRs
are listed in Supplemental Table S2. Each sample was an-
alyzed in triplicate, and the average Ct was calculated for
each primer set. In order to determine the Relative Nucle-
osome Occupancy associated with each primer set, the fol-
lowing equationwas used:RelativeNucleosomeOccupancy
= 10(Ct Untreated – Ct MNase).
Nuclear extracts preparation and co-immunoprecipitations
Nuclear protein extracts (NEs) were prepared using accord-
ing to the Lamond protocol (www.Lamondlab.com). For
co-immunoprecipitations, 300 g of NEs were first pre-
cleared with protein A sepharose (GE) for 2 h at 4◦C and
then incubated with the indicated antibodies or with rab-
bit IgG as a control. The antibodies were coupled to pro-
tein A-Sepharose beads following manufacturer’s instruc-
tions. Immunoprecipitations were carried out for 2 h at 4◦C
on a rotating wheel. Beads were then washed three times
with a solution composed of 10 mM Tris–HCl, 100 mM
NaCl, 0.01% Nonidet P-40, and 0.04% bovine serum albu-
min (BSA). The proteins bound to the beads were eluted
by boiling the samples at 95◦C for 10 min. Aliquots were
analyzed by SDS-PAGE and immunoblotting.
For ubiquitin immunoprecipitation, cells were lysed in
1% SDS lysis buffer (50 mM Tris–HCl pH 7.4, 0.5 mM
EDTA, 1% SDS) and further boiled for an additional 10
min. Lysates were clarified by centrifugation at 16 000 g for
10min. Supernatant was diluted 10 times with a buffer com-
posed of 50 mM Tris–HCl pH 7.4, 150 mM NaCl, 1% Tri-
ton and complete Protease Inhibitor Cocktail (Roche). Im-
munoprecipitation was performed with anti-Multi Ubiqui-
tin mAb-Agarose (MBL) overnight at 4◦C. The precipitates
were washed three times and the samples were resolved on
6% SDS-PAGE.
For Flag-tagged CstF50 immunoprecipitation, cells were
lysed as for ubiquitin immunoprecipitation. Immunopre-
cipitation was performed with ANTI-FLAGR© M2 Affinity
Gel (Sigma) overnight at 4◦C. The precipitates were washed
three times and eluted in a rotating wheel for 1 h at 4◦Cwith
a buffer containing 50mMTris–HCl pH7.4, 150mMNaCl,
1% Triton, complete Protease Inhibitor Cocktail (Roche)
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and 3× flag-peptide (5 g/ml). The samples were resolved
on 7% SDS-PAGE.
Formyc-tagged BARD1 immunoprecipitation, cells were
lysed in 50 mM Tris–HCl, pH 7.4, with 150 mM NaCl,
1 mM EDTA and 1% Triton X-100. Lysates were incu-
bated overnight at 4◦C with anti-myc antibody (71D10
Cell Signalling). The complexes were coupled to protein A-
Sepharose beads following manufacturer’s instructions. Im-
munoprecipitations were carried out for 2 h at 4◦C on a ro-
tating wheel. Beads were then washed three times with a so-
lution containing 10 mM Tris–HCl, 100 mM NaCl, 0.05%
Nonidet P-40, and 0.04% BSA. The proteins bound to the
beads were eluted by boiling the samples at 95◦C for 10min.
The sample were resolved on 7% SDS-PAGE.
Quantification of western blots was performed by using
NIH ImageJ software the Image Studio software (Odissey
FC-Licor) or Image Studio v1.1.
Statistical analysis
Statistical analysis of RT-PCR experiments was performed
either using a one-way ANOVA test followed by a post-hoc
Tukey–Kramer multiple comparison test, or a two-tailed,
paired t-test. Analysis of FACS experiments was carried
out using a one-way ANOVA test followed by a post-hoc
Tukey–Kramer multiple comparison test. Analysis of west-
ern blot data was performed using a two-tailed, paired t-
test.
RESULTS
BRM is down-regulated in response to oxidative stress
Oxidative stress has long been implicated in neuronal cell
death that is associated with neurodegenerative disorders.
For example, exposure of cells to paraquat (N,N’-dimethyl-
4,4′-bipyridinium dichloride, PQ), a neurotoxic herbicide,
increases the production of the superoxide anion (22), and
has been linked to the incidence of Parkinson’s disease.
Moreover, the second most frequent cause of hereditary
Amyotrophic Lateral Sclerosis (ALS) are mutations in the
cytoplasmic superoxide dismutase 1 (SOD1) protein and
have been shown to increases intracellular ROS levels (23).
We recently showed that treatment with PQ or expres-
sion of the mutant SOD1(G93A) protein cause extensive
changes in both mRNA expression and alternative splicing
in human neuroblastoma SH-SY5Y cells (16). Among the
most down-regulated genes was SMARCA2, the gene en-
coding BRM (Figure 1A and Supplementary Figure S1).
SOD1(G93A) expression almost abrogated BRM expres-
sion at the protein level, while expression of the hSWI/SNF
alternative ATPase subunit BRG1 was not significantly af-
fected (Figure 1B). Similarly, treatment of SH-SY5Y cells
with PQ strongly reduced BRM mRNA and protein levels
without affecting BRG1 expression (Supplementary Figure
S1). To test a possible causal link between oxidative stress
and BRM expression, we exposed primary adult fibroblasts
to different sources of ROS. Treatment with H2O2 (Figure
1C) or with PQ (Supplementary Figure S1) effectively re-
duced BRM expression.
We set out to identify regulatory elements in the
SMARCA2 promoter that respond to oxidative stress. In-
spection of the −3444/+57 region identified features asso-
ciated to promoter sequences (Supplementary Figure S2):
peaks of evolutionary conservation, a CpG island, a puta-
tive DNase hypersensitive region, and peaks of enrichment
of acetylation of histone 3 lysine 27 (H3KAc27). A high
GC-content and the absence of a detectable TATA-box sug-
gested that the promoter belongs to the class of GC pro-
moters. We then cloned a 3.4 kb genomic fragment (from
position –3344 to +57) into a promoter-less luciferase re-
porter. This region conferred sensitivity to PQ (Supplemen-
tary Figure S2) and showed reduced luciferase expression
when transfected in SH-SY5Y/SOD1(G93A) cells (Figure
1D). Further 5′ deletion analysis pointed to the −146/+57
fragment as critical for the oxidative stress response (Figure
1D). Addition of resveratrol, a natural antioxidant, to SH-
SY5Y/SOD1(G93A) cells reduced ROS production (Fig-
ure 1E) and restored luciferase expression to both the long
3344/+57 and the minimal -146/+57 promoter constructs
(Figure 1F).
Overall these results indicate that SMARCA2 transcrip-
tion and hence BRM expression are reduced by oxidative
stress.
Selection of the proximal alternative last exon is favored in
BRM-depleted cell
Using splicing-sensitive microarrays we had previously de-
tected a large number of AS changes (262 genes, involving
418 exons) in SH-SY5Y/SOD1(G93A) cells (16). Within
this dataset, 89 exons (in 78 genes) appeared as ALEs. We
validated by PCR six of these genes: in five out of six genes,
the distal ALE was favoured in the presence of BRM (i.e.
in SH-SY5Y/SOD1 cells), whereas the proximal ALE was
preferred when BRM was expressed at low level as in SH-
SY5Y/SOD1(G93A) cells (Figure 2A, and Supplementary
Figure S3).
We chose the RPRD1A gene for mechanistic analysis be-
cause of the ease of PCR quantification of the ALE choice.
As shown in Figure 2B, alternative splicing of theRPRD1A
primary transcript generates two mRNA variants with dif-
ferent terminal exons. When exon 8 (e8) is chosen as prox-
imal ALE, a shorter mRNA is produced. In contrast, a
longer mRNA isoform is generated when e8 is skipped and
cleavage and polyadenylation occur in the distal ALE exon
10 (e10). Exon e8 was preferentially skipped in SOD1 cells,
where BRM is expressed, while it was preferentially in-
cluded in SOD1(G93A) cells in which BRM is hardly de-
tected (Figure 2C and D). An inverse correlation between
BRM expression and e8 skipping was also found in SOD1
cells where BRM expression was silenced with a specific
shRNA (Figure 2C, and Supplementary Figure S4 for ex-
pression levels). Moreover, when BRMwas exogenously ex-
pressed in the SOD1(G93A) background, e8 was mostly
skipped and the mRNA variant ending in e10 was favoured
(Figure 2D, and Supplementary Figure S4 for expression
levels). In contrast, neither silencing of BRG1 in SOD1 cells
nor its overexpression in SOD1(G93A) cells affected the ra-
tio of the two mRNA isoforms (Figure 2C and D). The
transient transfection of expression constructs for BRM
and BRG1 in HEK293T cells further confirmed the BRM-
dependent inhibition of e8 selection (Figure 2E and Supple-
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Figure 1. Oxidative stress impairs BRM expression. (A) Both PQ and mutant SOD1(G93A) expression reduce the level of the SMARCA2 transcript.
qPCR validation of the gene-level microarray data of BRM expression in the indicated cell lines. Assays were performed in triplicate from three biological
replicates. (B) Left panel: representative western blot analysis of BRM and BRG1 in SH-SY5Y cells stably expressing wild type SOD1 or the mutant
SOD1(G93A) protein. Right panel: quantification of BRM and BRG1 protein levels from three independent biological replicates. Error bars represent
standard deviation. (C) Oxidative stress inhibits BRM expression in human fibroblasts. Representative western blot analysis of BRM and BRG1 in primary
fibroblasts treated with 0.2 mMH2O2 for 24 h. (D) Promoter activity of the 3.4 kb fragment containing the SMARCA2 regulatory region and its deletion
constructs in the indicated cell lines. Cells were transiently co-transfected with the indicated luciferase reporter plasmids and with the Renilla luciferase-
encoding pRL-TK plasmid. Renilla luciferase activity was used to normalize the transfection efficiency. Results are expressed as fold induction relative to
controls. Error bars represent standard deviations calculated on three independent experiments. Left panel: schematic representation of the SMARCA2-
promoter luciferase reporter plasmids used in transient transfection assays. (E) Expression of mutant SOD1(G93A) protein induces oxidative stress. Cells
were incubated with 20 M H2DCF-DA for 30 min at 37◦C and assayed by FACS as described under ‘Materials and Methods.’ Resveratrol was added
18 h prior to H2DHCF-DA incubation. Left panel: FACS profiles. Black filled, SH-SY5Y/SOD1 cells; grey filled, SH-SY5Y/SOD1(G93A) cells; empty,
resveratrol-treated SH-SY5Y/SOD1(G93A) cells. Right panel: quantification of H2DHCF-DA fluorescence. Statistical analysis was carried out using a
one-way ANOVA test followed by a post-hoc Tukey–Kramer multiple comparison test. **P< 0.01. Error bars represent standard deviations calculated on
three independent experiments. (F) Resveratrol treatment restores promoter activity of the −3344/+57 fragment and of the −146/+57 minimal promoter
in SH-SY5Y(SOD1) cells. Results are expressed as fold induction relative to vehicle-treated cells. Error bars represent standard deviations calculated on
three independent experiments.
mentary Figure S4 for expression levels). Similar results in
the different cell lines were obtained for the SLC6A15 gene
(Supplementary Figure S3).
Overall, these results indicate that a high expression level
of BRM favours the skipping of the proximal ALE of
RPRD1A.
BRM accumulates on the skipped proximal ALE
A well-known example of selection of alternative poly(A)
sites located in different terminal exons is provided by the
immunoglobulin mu (Ig) gene. The regulation of this pro-
cessing event was shown to depend on the different lev-
els of the 3′ end processing factor CstF during the mat-
uration from B cell to a plasma cell (24,25). We there-
fore tested the expression levels of the core cleavage and
polyadenylation factors in SH-SY5Y/SOD1 and in SH-
SY5Y/SOD1(G93A) cells, but did not detect significant dif-
ferences in the levels of CPSF, CstF and CF Im subunits
(data not shown).
BRM was previously shown to accumulate on the vari-
ant exon v5 of the CD44 gene and to promote its inclusion
bymodulating the elongation rate of RNAPII, and by inter-
actingwith the splicing factor Sam68 (26).We thus explored
the possibility that BRM could contribute to the choice of
ALE by regulating the elongation rate of the polymerase.
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Figure 2. BRM inhibits inclusion of the proximal ALE. (A) Alternative splicing pattern of the ALEs of four genes affected by BRMexpression. The splicing
pattern in the indicated cell lines was analyzed by RT-PCR and gel electrophoresis. For quantifications see Supplementary Figure S3. PLE: proximal ALE,
DLE: distal ALE. (B) Schematic representation of the relevant region of the RPRD1A gene indicating the positions of the PCR primers (arrowheads),
the splicing pattern and the size of the expected PCR products. (C) Stable knock-down of BRM, but not of BRG1, favors e8 inclusion in SOD1 cells.
(D) Stable overexpression of BRM, but not of BRG1, favors e10 inclusion in SOD1(G93A) cells. (E) Transient overexpression of BRM in HEK293T cells
favors e10 inclusion. C-E. Upper panels: The splicing pattern in the indicated cell lines was analyzed by RT-PCR and gel electrophoresis. Lower panel:
Quantification of proximal and distal ALE usage in the indicated cell lines. Data are representative of six independent experiments. Error bars represent
standard deviation. *P < 0.05 and ***P < 0.001.
First, we characterized the distribution of BRM and BRG1
along the terminal region of the RPRD1A gene from e6 to
e10 by chromatin immunoprecipitation (ChIP, Figure 3A).
In SOD1(G93A) cells, where it was hardly expressed, BRM
was distributed equally on all exons. In contrast, in SOD1
cells BRM accumulated on the proximal ALE (Figure 3B).
BRG1, on the other hand, was distributed equally on all ex-
ons in both the cellular lines (Figure 3C). Next, we analysed
the distribution of the elongating polymerase, using theN20
antibody that recognizes theN-terminal region of RNAPII.
An increased density of RNAPII was detected on e7 and e8
in SOD1(G93A) cells and in both cell lines on e10 (Figure
3D).We also performed ChIP assays with theH14 antibody
to RNAPII phosphorylated at Ser5 of the CTD, a modifi-
cation associated with a paused polymerase (27,28) (Figure
3E). We detected a slight accumulation of p-Ser5 RNAPII
on e8 in SOD1(G93A) cells. In addition, we observed a high
density on e10 in both cell lines, where this exon is used as
terminal exon, albeit with different efficiency. This result is
reminiscent of the observed pausing of RNAPII on termi-
nal exons in yeast (29).
Our findings indicate a modest inverse correlation be-
tween the accumulation of BRM and the accumulation
of RNAPII on included exons. Thus, the contribution of
RNAPII pausing to the inclusion of the proximal exon ap-
pears small, at variance with what previously observed for
the inclusion of internal exons (26).
BRM does not require its ATPase activity to affect ALE
choice
The SWI/SNF chromatin-remodeling complex destabilizes
histone-DNA interactions and alters nucleosome positions.
Recent studies indicate that nucleosome positioning may
influence inclusion of internal exon sequences (30,31). We
therefore wondered whether BRM might contribute to the
choice of ALE by moving nucleosomes around the proxi-
mal last exon. We thus identified nucleosome positions and
occupancy in SOD1 and SOD1(G93A) cells, using micro-
coccal nuclease (MNase) digestion in cells synchronized in
G0. We used mononucleosomal DNA fragments (150 bp)
generated by MNase as a template for qPCR with overlap-
ping primer sets across a∼1 kb region centered on e8 of the
human RPRD1A genomic locus. As shown in Figure 4A,
the MNase digestion pattern did not significantly differ be-
tween the two cell lines, indicating that the level of BRM
protein had no influence on nucleosome distribution in the
interrogated region of the RPRD1A gene.
To further exclude that the chromatin remodeling activity
of BRM-containing SWI/SNF complexes may contribute
to e8 skipping in SOD1 cells, we analysed the alternative
splicing pattern in SH-SY5Y cells stably expressing a BRM
mutant carrying the K755A substitution in the ATPase do-
main that abrogates the chromatin remodeling activity (19)
(Figure 4B, and Supplementary Figure S4 for expression
levels) we also analysed HEK293T cells transiently trans-
fected with the same construct (Figure 4C, and Supplemen-
tary Figure S4 for expression levels). Similarly to the wild
type, expression of themutant BRMstimulated exon 8 skip-
ping and the selection of the distal ALE.
Taken together these data indicate that the chromatin re-
modeling function of BRM is not required for the inhibi-
tion of the inclusion of the proximal ALE in SOD1 cells.
Therefore, we hypothesized that BRM might contribute to
e8 skipping by negatively acting on pre-mRNA processing,
possibly by recruiting an inhibitory complex.
BARD1 and CstF50 associate with BRM on the skipped
proximal ALE
Previously, a BARD1-CstF complex was shown to inhibit
3′ processing of nascent transcripts deriving from prema-
ture transcription termination at sites of DNA damage
(14,17,32). Therefore, we speculated that BARD1 (and its
partner BRCA1) might also be involved in the inhibition
of transcription termination at the proximal poly(A) site.
Indeed, we found that endogenous BRCA1 and BARD1
in HEK293T cells co-immunoprecipitate with SNF5 and
BRM (Figure 5A), indicating that both proteins can asso-
ciate with the SWI/SNF complex.
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Figure 3. BRM localizes on the excluded proximal ALE of RPRD1A gene. (A) Schematic representation of the relevant region of the RPRD1A gene
indicating the splicing pattern and the positions of the qPCR primers used for ChIP analysis (arrowheads). (B–E) BRM, BRG1, and RNAPII on the
RPRD1A gene. ChIP assays were performed with the indicated antibodies on bulk chromatin from SH-SY5Y/SOD1 and SH-SY5Y/SOD1(G93A) cells.
The graphs show the recruitment of the indicated proteins relative to the values obtained with the non-immune sera. Data are representative of three
independent experiments. Error bars represent s.e.m.
Next, we determined that in SOD1 cells, where BRM is
present at higher level, BARD1 is recruited on theRPRD1A
gene on e8 (Figure 5B). Conversely, in SOD1(G93A) cells
BARD1 was enriched on e7. We then showed that BRM
and BARD1 were present on the same DNA fragments by
performing two successive ChIP assays (ChIP-reChIP) us-
ing anti-BRM followed by anti-BARD1 antibodies (Figure
5C). Finally, overexpression of BRM and BARD1 proteins
(Supplementary Figure S4 for expression levels) favoured
the inclusion of the distal ALE (Figure 5D),
Taken together, these data indicate that BARD1 and
BRCA1 are integral to the process of ALE choice.
TheBARD1/BRCA1 complex promotes the ubiquitination of
CstF50
BARD1 and CstF50 were shown to interact both in vitro
and in vivo (10,14,17). We confirmed this interaction by co-
transfecting HEK293T cells with plasmids expressing myc-
tagged BARD1 and Flag-tagged CstF50. Immunoprecipi-
tation with either anti-myc or anti-Flag antibodies followed
by western blotting demonstrated that BARD1 and CstF50
interact physically (Figure 6A).Moreover, ChIP-reChIP ex-
periments using anti-BARD1 followed by CstF50 antibod-
ies demonstrated that BARD1 and CstF50 co-assemble on
e8 of RPRD1A in SOD1 cells, where the distal ALE is pref-
erentially selected (Figure 6B).
Since BRCA1 has E3-ubiquitin ligase activity (33), we
wondered whether the interaction between BARD1 and
CstF50 may lead to CstF50 ubiquitination. HEK293T cells
were contransfected with plasmids encoding Flag-CstF50
and histidine-tagged ubiquitin. Indeed, CstF50 immuno-
precipitated with an anti Flag-antibody and tested positive
to the His-specific antibody (Figure 6C). We further veri-
fied if a fraction of CstF is always ubiquitinated in unper-
turbed cells. To this end, cells were lysed under denaturing
conditions and the ubiquitinated protein fraction was im-
munoprecipitated with an anti-ubiquitin antibody. Western
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Figure 4. BRM ATPase activity is not required for ALE choice. (A) Nucleosome occupancy profile of the relevant region of the RPRD1A gene in G0-
synchronized cells. Lines indicate the positions of the qPCR primers. Nucleosome positioning was analyzed with MNase digestion for the 33 605 100–33
606 100 region of human chromosome 18 containing theRPRD1A gene in SH-SY5Y/SOD1 and in SH-SY5Y/SOD1(G93A) cells. Data are representative
of three independent biological replicates. Error bars represent s.e.m.. (B and C) BRM ATPase activity is not required for exon 8 skipping. The splicing
pattern was analyzed by RT-PCR and quantified as percentage of proximal and distal ALEs. Data are representative of six independent experiments. Error
bars represent standard deviations. *P < 0.05 and **P < 0.01.
blot analysis with an anti-CstF50 antibody confirmed the
ubiquitination of CstF50 (Figure 6D).
We next investigated whether the BRCA1 E3 ubiqui-
tin ligase activity was responsible for the ubiquitination
of CstF50. To this end, BRCA1 was transiently silenced
with a specific siRNA. Three days after transfection the
level of the BRCA1 protein was reduced to ∼25% (Sup-
plementary Figure S4). Immunoprecipitation of the ubiq-
uitinated protein fraction with an anti-ubiquitin antibody
from BRCA1-silenced cell extracts showed a reduction
in the amount of ubiquitinated CstF50 protein (Figure
7A). Moreover, expression of deltaN-BRCA1 protein, lack-
ing the amino-terminal RING domain (34), reduced the
amount of ubiquitinated CstF50 (Figure 7B). Together
these results confirm the BRCA1/BARD1-mediated ubiq-
uitination of CstF50.
Finally, we determined the effect BRCA1 silencing on
pre-mRNA splicing. As shown in Figure 7C, siRNA-
mediated knockdown of endogenous BRCA1 resulted in
the preferred inclusion of the proximal ALE.
Overall these results suggest a model in which BRM po-
sitioned on the proximal ALE mediates the recruitment of
the BARD1/BRCA1 complex, which in turn ubiquitinates
CstF50 impairing 3′ end processing at the proximal poly(A)
site. This allows transcription to proceed to the distal termi-
nal exon.
DISCUSSION
Oxidative stress is a common biological event, and has been
associated with cancer, neurodegenerative diseases and ag-
ing. We previously reported that oxidative stress affects
splice site selection (16). Here, we show that it affects in par-
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Figure 5. BRM and BARD1 accumulate on the excluded proximal ALE. (A) BARD1 and BRCA1 associate with the SWI/SNF complex. Immunoprecip-
itations were carried out with the indicated antibodies (IP) from HEK293T nuclear extracts. Filters were sequentially probed with the indicated antibodies
(WB). (B) BARD1 is enriched on theRPRD1A gene. ChIP assays were performed with the indicated antibodies on bulk chromatin from SH-SY5Y/SOD1
and SH-SY5Y/SOD1(G93A) cells. The graphs show the recruitment of the indicated proteins relative to the values obtained with the non-immune Ig. Data
are representative of three independent experiments. Variability is expressed as SEM. (C) ChIP-reChIP was performed for BRM and BARD, and analyzed
by PCR (upper panel) and qPCR (lower panel). Data are representative of three independent experiments. Error bars represent standard deviations. (D)
Transient overexpression of BRM, and BARD1 in HEK293T cells promotes skipping of the proximal ALE. Error bars represent standard deviations. *P
< 0.05, **P < 0.01.
ticular the choice of ALEs, generally promoting the inclu-
sion of the proximal ALE; it does so by inducing a severe
decrease in the expression of the SWI/SNF subunit BRM.
Our data also provide evidence for a regulatory mecha-
nism that partially inhibits 3′ end processing at the proximal
poly(A) site.
Recently, knock-down of Brm and of other SWI/SNF
subunits was shown to affect splicing-associated polyadeny-
lation in Drosophila S2 cells by an unknown mechanism
(35). We suggest that the involvement of BRM-containing
SWI/SNF complexes in the regulation of pre-mRNA pro-
cessing is similar in Drosophila and mammalian cell, and
thus is conserved in evolution, and possibly not restricted
to the choice of ALE choice following oxidative stress.
We specifically analyse the ALE choice on RPRD1A
gene, which generates two main mature transcripts: one in-
cluding exons 1–7 followed by exon 8 (the proximal ALE)
and the polyA, and one where exons 1–7 are followed by
exons 9–10 and polyA. Both mature transcripts are present
in cells, whether undergoing oxidative stress or not, but
their relative abundance changes. We find that BRM is as-
sociated with RPRD1A e8 in normal conditions, whereas
oxidative stress strongly reduces BRM expression and its
association with e8. BRM and SNF5 (another core sub-
unit of the SWI/SNF complex) co-immunoprecipitate the
BRCA1/BARD1E3 ubiquitin ligase. Indeed, our ChIP and
ChIP-ReChIP experiments reveal that BRM, BARD1 and
CstF co-accumulate on e8 in SOD1 cells, inwhich the choice
of the distal ALE is promoted. Likewise, overexpression
of BRM and BARD1 proteins promoted the choice of the
distal ALE. Further, we show that BRCA1/BARD1 me-
diates the ubiquitination of CstF50. Mutation or silencing
of BRCA1 reduces CstF50 ubiquitination, and promoted
the choice of the proximal ALE. We thus propose that the
presence of BRM on the proximal ALE promotes the re-
cruitment of the BARD1/BRCA1 ubiquitin ligase, which
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Figure 6. A fraction of CstF50 is ubiquitinated. (A) BARD1 and CstF50 physically interact. Cell lysates prepared from HEK293T cells and transfected
with the indicated plasmids were immunoprecipitated with anti-FLAG (upper panel) or anti-Myc (lower panel) coniugated beads. Input (10% of the
extract) and coimmunoprecipitated proteins were analyzed by western blots with the indicated antisera. (B) Both BARD1 and CstF50 are enriched on the
RPRD1A gene. Quantitative PCR analysis of ChIP-reChIP assays for BARD1 andCstF50.Data are representative of three independent experiments. Error
bars represent standard deviations. (C) CstF50 is ubiquitinated in HEK cells overexpressing his-tagged ubiquitin. HEK293T cells were cotransfected with
plasmids expressing Flag-tagged CsF50 and His-ubiquitin. Total extracts were boiled in 1% of SDS lysis buffer, diluted tenfold, and immunoprecipitated
with anti-FLAG coniugated beads (IP). Input (1% of the extract) and immunoprecipitated proteins were analyzed by western blotting with the indicated
antisera. The arrowhead indicates the His-tagged CstF50 protein. The shift is consistent with a monoubiquitination. (The samples were run on the same
gel but the lanes were rearranged for clarity). (D) A fraction of CstF50 is ubiquitinated in unperturbed HEK cells. Whole cell extracts were prepared
from HEK293T cells and immunoprecipitated with an anti-ubiquitin conjugated resin. Input (1% of the extract) and coimmunoprecipitated proteins were
analyzed by western blotting with an anti-CstF50 antiserum.
by ubiquitinating CstF50 causes the inhibition of 3′ end
processing at the proximal poly(A) site and allows the con-
tinuation of transcription through exons 9–10. A fraction of
the pool of CstF50 is always monoubiquitinated, which is
consistent with the fact that some transcripts incorporating
the distal ALE are always present.
Our findings are consistent with previous knowledge. The
coupling of transcription and 3′ end processing is well docu-
mented (reviewed in (1,9)). RNAPII and other transcription
factors interact with components of the 3′-end-processing
machinery (36–39)). Generally, these interactions appear
to promote the use of the proximal poly(A) site, since this
is transcribed first and is encountered first by the 3′-end-
processing machinery. Cleavage and polyadenylation at the
proximal poly(A) site is favoured by a reduction of the elon-
gation rate of the transcribing polymerase (40). In this re-
spect, it not surprising that the mechanism we describe re-
strains the cleavage of the nascent transcript.
In vivo BARD1 can interact with BRCA1 (41) and the
BARD1/BRCA1 heterodimer has E3 ubiquitin ligase ac-
tivity (33). Moreover, BRCA1 interacts with the SWI/SNF
chromatin remodeling complex (42). Finally, the interac-
tion between CstF50 and BARD1 in UV-treated cells was
shown to inhibit erroneous 3′ processing of nascent, trun-
cated transcripts deriving from premature transcription ter-
mination at sites of DNA damage (14,17,32).
BRM has already been implicated in alternative splic-
ing: it was previously shown to promote inclusion of vari-
ant internal exons of the CD44 gene by inducing a tran-
sient pausing of the transcribing RNAPII (26). However,
inDrosophila, Brm-containing SWI/SNF complexes, while
inducing RNAPII pausing, can negatively regulate splic-
ing (43). In this case, RNAPII stalling, and the consequent
splicing reduction, were not induced by Brm but were rather
dependent on SNF5. Instead, Brm remodeling activity was
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Figure 7. Ubiquitination of CstF50 is catalyzed by BRCA1. (A) BRCA1 knockdown impairs CstF50 ubiquitination. Whole cell extracts from HEK293T
cells transfected with control or BRCA1 siRNAs were immunoprecipitated with a control or an anti-ubiquitin resin. Western blots were analysed with
the indicated antibodies. -catenin was used as control for BRCA1-independent ubiquitination and is highlighted by an arrow. The asterisk indicates
non-specific bands. Upper panel: Quantification of CstF50 ubiquitination upon BRCA1 silencing. Quantification was performed on three independent
immunoprecipitation experiments. Immunoprecipitated CstF50 protein was normalized on -catenin. Error bars represent standard deviations. Lower
panel: representative western blot. (B) Overexpression of a catalytically inactive mutant BRCA1 protein impairs CstF50 ubiquitination. HEK293T cells
were cotransfected with plasmids expressing CstF50, BARD1 and either wild type BRCA1 or the BRCA1-N mutant. Ubiquitinated proteins were
immunoprecipitated with an anti-ubiquitin resin as described in ‘Materials and Methods’ and analysed by western blotting with the indicated antisera.
Upper panel: Quantification was performed on three independent immunoprecipitation experiments. Immunoprecipitated CstF50 protein was normalized
on IgG bands that are indicated in the Ponceau Staining. Error bars represent standard deviations. *P< 0.05. Lower panel: representative western blot. The
arrow indicates the bands corresponding to the IgGs. (C) BRCA1 knockdown favors inclusion of the distal ALE. Quantification of the amount of proximal
and distal ALE usage in the indicated cell lines. Data are representative of three independent experiments. Error bars represent standard deviation. ***P
< 0.001.
shown to be necessary for the subsequent chromatin remod-
eling following the release of the stalled polymerase (43).
In line with the report by Zraly et al. (43), we found that
BRM negatively affects the inclusion of the proximal ALE.
This effect does not require its ATPase activity. Moreover,
we did not detect differences in the distribution of nucleo-
somes on the proximal ALE. These findings suggest that the
choice ofALE is not correlatedwith the nucleosome remod-
eling activity of BRM.We also observed thatRNAPII is not
greatly enriched on the skipped proximal ALE. Instead, we
observed an inverse correlation between the accumulation
of BRMandRNAPII particularly on the distal ALE, where
there was a distinct enrichment of RNAPII but BRM was
virtually absent. Our data indicate that in the case of the
choice of alternative terminal exons, the modulation of the
elongation rate of RNAPII is not the main role of BRM,
and rather implicate a different molecular mechanism.
The choice of alternative poly(A) sites located in differ-
ent terminal exons occurs in conjunction with splicing, and
splicing factors are known to influence 3′ processing (re-
viewed in (44)). Thus, the mechanism we describe is cer-
tainly not the unique determinant of the choice between
proximal and distal terminal exons. Moreover, we cannot
exclude that BRM and BRCA1/BARD1 may also affect
binding of splicing factors to the terminal exon. Future
work will determine how the interplay between chromatin
remodeling complexes, splicing and polyadenylation factors
eventually determines which terminal exon will be included
in the mature transcript.
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